# FDA Inspection 1326094 - Tomasz M. Ziedalski, M.D. - July 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/tomasz-m-ziedalski-md/593f41e4-b954-4cae-a316-b814b34725b6
Source feed: FDA_Inspections

> FDA Inspection 1326094 for Tomasz M. Ziedalski, M.D. on July 09, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326094
- Company Name: Tomasz M. Ziedalski, M.D.
- Inspection Date: 2026-07-09
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Office Name: Seattle District Office

Company: https://www.keypedia.com/companies/tomasz-m-ziedalski-md/f81bfc7e-3ab7-41fa-8885-9e775d48598f

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913